Novartis5d
Adults in Scotland with rare blood disorder to get access to new oral monotherapy on NHS
Scottish Medicines Consortium (SMC) has recommended Fabhalta® (iptacopan) as monotherapy for adults with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia and used under the ...
Novartis10d
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by ...
Novartis3d
Corporate Social Responsibility
At Novartis, we have a strong commitment to sustainable development. As a global organization, we recognize the opportunity to drive positive social change. We are on a continuous journey to channel ...
Novartis6d
Career Search
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Novartis5d
Careers at Novartis in Slovenia
At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...
Novartis9d
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
Novartis8h
Rechercher de Carrières
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Novartis13h
Openstaande vacatures bij Novartis
Bekijk hieronder de opportuniteiten bij Novartis. Voor functies bij Novartis Gene Therapies (voorheen AveXis), ga naar GTx Career Search. Renal / Rare Disease Territory Account Specialist – San ...
Novartis1d
Presentan una guía pionera en España para la profesionalización de las entidades de pacientes
Un 62% de las entidades de pacientes coinciden en que la profesionalización de sus organizaciones es uno de los principales retos a los que se enfrentan. Un hecho que impacta, según estas entidades, ...
Novartis11h
Αναζήτηση θέσεων εργασίας
Εξερευνήστε ευκαιρίες στη Novartis και στη Sandoz παρακάτω. Για επιπλέον ρόλους στη Novartis Gene Therapies (πρώην AveXis) επισκεφτείτε την Αναζήτηση ...
Novartis20d
Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA
The Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with SMA treated with intrathecal onasemnogene abeparvovec (OAV101 IT) OAV101 IT ...